Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 8/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 7/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 1.00 |
| ▸ | XDH | P47989 | 6/20 | 0.84 |
| ▸ | DPP4 | P27487 | 4/20 | 0.84 |
| ▸ | MEN1 | O00255 | 8/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.82 |
| ▸ | IPMK | Q8NFU5 | 6/20 | 0.82 |
| ▸ | IP6K2 | Q9UHH9 | 6/20 | 0.82 |
| ▸ | CA12 | O43570 | 3/20 | 0.82 |
| ▸ | CA2 | P00918 | 3/20 | 0.82 |
| ▸ | PPARG | P37231 | 3/20 | 0.82 |
| ▸ | CA7 | P43166 | 3/20 | 0.82 |
| ▸ | CA4 | P22748 | 2/20 | 0.82 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.80 |
| ▸ | TUBB | P07437 | 1/20 | 0.80 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.80 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.80 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.80 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tamarixetin SCHEMBL29750609 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Tamarixetin SCHEMBL30255798 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| SCHEMBL30256517 | 0.93 | MEN1 (0.86) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| SCHEMBL29575749 | 0.93 | MEN1 (0.86) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| SCHEMBL3211188 | 0.93 | MEN1 (0.86) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Ombuine SCHEMBL29475881 | 0.91 | XDH (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Ombuine SCHEMBL1252211 | 0.91 | XDH (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Ombuine SCHEMBL31516400 | 0.91 | XDH (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Isorhamnetin SCHEMBL19235 | 0.90 | MEN1 (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 | |
| Isorhamnetin SCHEMBL30385934 | 0.90 | MEN1 (1.00) | CYP1A2CYP1A1CYP1B1XDHDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514278-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2026-01-06 | — | — | US | claimed |
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| US-20250042765-A1 | METHOD FOR TREATING A SURFACE CONTAMINATED WITH PSEUDOMONAS AERUGINOSA | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-02-06 | — | — | US | claimed |
| US-12157677-B2 | Method for treating a biologically contaminated surface | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-12-03 | — | — | US | claimed |
| WO-2024156359-A1 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| EP-4401713-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4401712-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4401711-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4401714-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| US-20130184227-A1 | Cytochrome P450 2C9 Inhibitors | HU OLIVER YOA-PU (TW) | 2013-07-18 | — | — | US | claimed |
| WO-2013037603-A1 | QUERCETIN FOR BROWNING FOOD SURFACES | NESTEC S.A. (CH) | 2013-03-21 | — | — | WO | claimed |
| US-8304394-B2 | Low side effect pharmaceutical composition containing isoniazid | NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION (TW) | 2012-11-06 | — | — | US | claimed |
| US-20110207684-A1 | NEW LOW SIDE EFFECT PHARMACEUTICAL COMPOSITION CONTAINING ISONIAZID | NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION (TW) | 2011-08-25 | — | — | US | claimed |
| US-20110034427-A1 | Anti-aging properties of quercetin, 18alpha-glycyrrhetinic acid and hederagenin and their derivatives | KORRES S.A. NATURAL PRODUCTS (GR) | 2011-02-10 | — | — | US | claimed |
| EP-1569628-B1 | NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING | DSM IP ASSETS BV (NL) | 2009-07-22 | — | — | EP | claimed |
| US-20060069042-A1 | Cytochrome P450 2C9 inhibitors | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2006-03-30 | — | — | US | claimed |
| CN-1720030-A | The new purposes of lycopene | DSM IP ASSETS BV (NL) | 2006-01-11 | — | — | CN | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-5631038-A | COMPOUNDS (TASTANDS) TO REDUCE OR ELIMINATE A BITTER OR METALLIC TASTE ARE ADDED TO FOODS CONTAINING SODIUM CHLORIDE | BIORESEARCH, INC. (US) | 1997-05-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034427-A1 | Anti-aging properties of quercetin, 18alpha-glycyrrhetinic acid and hederagenin and their derivatives | GLA, AGER, CUTA | CYP1A2 1047/4885CYP1A1 1329/4885CYP1B1 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.